Enjoy complimentary customisation on priority with our Enterprise License!
The contract research organization (CRO) market size is forecast to increase by USD 63.35 billion at a CAGR of 12.61% between 2023 and 2028. The market is experiencing significant growth due to the expanding biopharmaceutical industry and the increasing number of clinical trials in various therapeutic areas, including CNS disorders therapeutics, cardiology research, metabolic disorders, and infectious disease trials. Pharmaceutical sponsors and providers of medical devices are outsourcing an increasing number of clinical trials to CROs to reduce costs, improve efficiency, and enhance the quality of research. However, intellectual property (IP) issues pose a challenge to the growth of the CRO industry, as disputes over IP ownership and licensing can lead to delays and increased costs. To remain competitive, CROs must provide innovative solutions to IP challenges and ensure compliance with regulatory requirements.
_market_size_abstract_2024_v1.jpg.webp?v4.1.20)
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.